nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgments
|
|
|
1995 |
26 |
4S2 |
p. S4- 1 p. |
artikel |
2 |
Executive summary
|
|
|
1995 |
26 |
4S2 |
p. S12-S19 8 p. |
artikel |
3 |
III. Incidence and causes of treated ESRD
|
|
|
1995 |
26 |
4S2 |
p. S39-S50 12 p. |
artikel |
4 |
II. Prevalence of ESRD therapy
|
|
|
1995 |
26 |
4S2 |
p. S30-S38 9 p. |
artikel |
5 |
Introduction
|
Held, Philip J. |
|
1995 |
26 |
4S2 |
p. S1-S3 3 p. |
artikel |
6 |
I. The USRDS and its products
|
|
|
1995 |
26 |
4S2 |
p. S20-S29 10 p. |
artikel |
7 |
IV. ESRD treatment modalities
|
|
|
1995 |
26 |
4S2 |
p. S51-S68 18 p. |
artikel |
8 |
IX. Hospitalization
|
|
|
1995 |
26 |
4S2 |
p. S129-S139 11 p. |
artikel |
9 |
List of common acronyms
|
|
|
1995 |
26 |
4S2 |
p. S9-S11 3 p. |
artikel |
10 |
VI. Causes of death
|
|
|
1995 |
26 |
4S2 |
p. S85-S94 10 p. |
artikel |
11 |
VIII. Pediatric end-stage renal disease
|
|
|
1995 |
26 |
4S2 |
p. S112-S128 17 p. |
artikel |
12 |
VII. Renal transplantation: Access and outcomes
|
|
|
1995 |
26 |
4S2 |
p. S95-S111 17 p. |
artikel |
13 |
V. Patient mortality and survival
|
|
|
1995 |
26 |
4S2 |
p. S69-S84 16 p. |
artikel |
14 |
Who's who in the USRDS
|
|
|
1995 |
26 |
4S2 |
p. S5-S8 4 p. |
artikel |
15 |
XI. Facility survey of providers of ESRD therapy
|
|
|
1995 |
26 |
4S2 |
p. S157-S160 4 p. |
artikel |
16 |
XII. International comparisons of ESRD therapy
|
|
|
1995 |
26 |
4S2 |
p. S161-S166 6 p. |
artikel |
17 |
XIII. USRDS research studies
|
|
|
1995 |
26 |
4S2 |
p. S167-S173 7 p. |
artikel |
18 |
XIV. Analytical methods
|
|
|
1995 |
26 |
4S2 |
p. S174-S186 13 p. |
artikel |
19 |
X. The cost effectiveness of alternative types of vascular access and the economic cost of ESRD
|
|
|
1995 |
26 |
4S2 |
p. S140-S156 17 p. |
artikel |